Pharmocann Global Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Pharmocann Global has been growing earnings at an average annual rate of 15.6%, while the Pharmaceuticals industry saw earnings growing at 10.3% annually. Revenues have been declining at an average rate of 9.1% per year.

Anahtar bilgiler

15.6%

Kazanç büyüme oranı

40.5%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi35.1%
Gelir büyüme oranı-9.1%
Özkaynak getirisi-4,587.4%
Net Marj-76.1%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence

Mar 30
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence

Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?

Feb 04
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?

Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 31
Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come

Nov 26
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come

Gelir ve Gider Dağılımı

Pharmocann Global nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

TASE:PMCN-M Gelir, gider ve kazançlar (ILS Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2413-1080
31 Mar 2414-1080
31 Dec 2314-1080
30 Sep 2311-1260
30 Jun 2312-1871
31 Mar 2317-24101
31 Dec 2223-25131
30 Sep 2224-23121
30 Jun 2225-20131
31 Mar 2228-16151
31 Dec 2129-19151
30 Sep 2131-14151
30 Jun 2132-7151
31 Mar 21312131
31 Dec 20284131
30 Sep 20266111
30 Jun 20265101
31 Mar 2021-2591
31 Dec 1921-4661
30 Sep 1918-4660
30 Jun 1917-4640
31 Mar 1916-2040
31 Dec 1815630
31 Dec 1712230
31 Dec 169120

Kaliteli Kazançlar: PMCN-M is currently unprofitable.

Büyüyen Kar Marjı: PMCN-M is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: PMCN-M is unprofitable, but has reduced losses over the past 5 years at a rate of 15.6% per year.

Büyüme Hızlandırma: Unable to compare PMCN-M's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: PMCN-M is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (7.1%).


Özkaynak Getirisi

Yüksek ROE: PMCN-M has a negative Return on Equity (-4587.44%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin